Alaska Permanent Fund Corp 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 07:08 am Sale | 2020-12-31 | 13G | Vir Biotechnology, Inc. VIR | Alaska Permanent Fund Corp | 3,893,040 3.060% | -1,662,516 (-29.93%) | Filing |